EP2953631 - METHODS OF TREATING HEART FAILURE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.01.2018 Database last updated on 22.08.2024 | |
Former | Request for examination was made Status updated on 10.10.2017 | Most recent event Tooltip | 26.01.2018 | Application deemed to be withdrawn | published on 28.02.2018 [2018/09] | Applicant(s) | For all designated states The Trustees of The University of Pennsylvania 3160 Chestnut Street Suite 200 Philadelphia, PA 19104 / US | [N/P] |
Former [2015/51] | For all designated states The Trustees Of The University Of Pennsylvania 3160 Chestnut Street, Suite 200 Philadelphia, PA 19104 / US | Inventor(s) | 01 /
CHIRINOS, Julio A. 3166 Still Wood Lane Garnet Valley, PA 19106 / US | [2015/51] | Representative(s) | Leonard, Thomas Charles, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
Former [2015/51] | Leonard, Thomas Charles, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 14749378.7 | 07.02.2014 | [2015/51] | WO2014US15300 | Priority number, date | US201361761863P | 07.02.2013 Original published format: US 201361761863 P | [2015/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014124256 | Date: | 14.08.2014 | Language: | EN | [2014/33] | Type: | A1 Application with search report | No.: | EP2953631 | Date: | 16.12.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.08.2014 takes the place of the publication of the European patent application. | [2015/51] | Search report(s) | International search report - published on: | US | 14.08.2014 | (Supplementary) European search report - dispatched on: | EP | 30.01.2017 | Classification | IPC: | A61K33/00, A61K36/185, A61P9/04 | [2016/36] | CPC: |
A61K45/06 (EP,US);
A61K33/00 (US);
A61K33/30 (EP,US);
A61K36/185 (EP,US);
A61P9/04 (EP);
A61K36/21 (EP,US)
| C-Set: |
A61K33/30, A61K2300/00 (EP,US);
A61K36/185, A61K2300/00 (US,EP) |
Former IPC [2015/51] | A61K33/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/51] | Extension states | BA | 04.09.2015 | ME | 04.09.2015 | Title | German: | VERFAHREN ZUR BEHANDLUNG VON HERZVERSAGEN | [2015/51] | English: | METHODS OF TREATING HEART FAILURE | [2015/51] | French: | PROCÉDÉS DE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE | [2015/51] | Entry into regional phase | 04.09.2015 | National basic fee paid | 04.09.2015 | Search fee paid | 04.09.2015 | Designation fee(s) paid | 04.09.2015 | Examination fee paid | Examination procedure | 04.09.2015 | Examination requested [2015/51] | 12.04.2016 | Amendment by applicant (claims and/or description) | 29.08.2017 | Application deemed to be withdrawn, date of legal effect [2018/09] | 11.10.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/09] | Fees paid | Renewal fee | 26.02.2016 | Renewal fee patent year 03 | 27.02.2017 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2005004884 (US GOV HEALTH & HUMAN SERV [US], et al) [A] 1-6,8-14 * claim - *; | [I]WO2012076667 (SOLVOTRIN INNOVATIONS LTD [IE], et al) [I] 1-6,8-14 * claim - *; | [XI]US2012214818 (DUDLEY SAMUEL [US]) [X] 1 * paragraph [0152] * [I] 2-6,8-14; | [A]WO2012142413 (THERAVASC INC [US], et al) [A] 1-6,8-14 * claim - *; | [E]WO2014134585 (AIRES PHARMACEUTICALS INC [US], et al) [E] 1-6,8-14* claim - *; | [I] - AARON M. FROM ET AL, "Heart Failure with Preserved Ejection Fraction: Pathophysiology and Emerging Therapies", CARDIOVASCULAR THERAPEUTICS, (20110829), vol. 29, no. 4, doi:10.1111/j.1755-5922.2010.00133.x, ISSN 1755-5914, pages e6 - e21, XP055285664 [I] 1-6,8-14 * page e12 * DOI: http://dx.doi.org/10.1111/j.1755-5922.2010.00133.x | [I] - A. R. MAHER ET AL, "Hypoxic Modulation of Exogenous Nitrite-Induced Vasodilation in Humans", CIRCULATION, US, (20080205), vol. 117, no. 5, doi:10.1161/CIRCULATIONAHA.107.719591, ISSN 0009-7322, pages 670 - 677, XP055286107 [I] 1-6,8-14 * table 2 * DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.107.719591 | [I] - SCOTT K. FERGUSON ET AL, "Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats", THE JOURNAL OF PHYSIOLOGY, GB, (20121203), vol. 591, no. 2, doi:10.1113/jphysiol.2012.243121, ISSN 0022-3751, pages 547 - 557, XP055286236 [I] 1-6,8-14 * table 3 * DOI: http://dx.doi.org/10.1113/jphysiol.2012.243121 | [I] - Anonymous, "Dietary Nitrates for Heart Failure - Full Text View - ClinicalTrials.gov", (20120905), URL: https://clinicaltrials.gov/ct2/show/NCT01682356, (20160706), XP055286243 [I] 1-6,8-14 * the whole document * | International search | [X]US2010092441 (LUNDBERG JON [SE], et al); | [Y]US2012208762 (DUDLEY SAMUEL [US]); | [X] - LEE ET AL., "Aging and Arterial Stiffness.", CIRCULATION JOURNAL, (201011), vol. 74, pages 2257 - 2262, XP055273535 DOI: http://dx.doi.org/10.1253/circj.CJ-10-0910 | [X] - OLIVER ET AL., "Clinical Potential of Combined Organic Nitrate and Phosphodiesterase Type 5 Inhibitor in Treatment-Resistant Hypertension.", HYPERTENSION, (20100517), pages 62 - 67, XP055273537 DOI: http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.147686 | [A] - MOHAMMED ET AL., "Comorbidity and Ventricular and Vascular Structure and Function in Heart Fialure With Preserved Ejection Fraction: A Community-Based Study.", CIRCULATION HEART FAILURE, (20121017), pages 710 - 729, XP055273540 DOI: http://dx.doi.org/10.1161/CIRCHEARTFAILURE.112.968594 |